R(-)-10,11-alkylenedioxy-n-alkylnorapomorphine

Abstract From the Canadian patent

of Disclosure, A method for providing orally effective aporphine compounds, and new compounds which are orally effective in the prevention and treatment of duodenal ulcers and in the treatment of neurological and psychiatric disorders having the following formula, wherein R1 is lower alkyl substituted lower alkyl, cycloalkyl, substituted cycloalkyl lower alkenyl, substituted lower alkenyl lower alkynyl, substituted lower alkynyl phenyl lower alkyl, phenyl lower alkenyl and phenyl lower alkynyl R2 and R3 are, hydrogen, methyl, lower alkyl substituted lower alkyl, cyclo-, alkyl substituted cycloalkyl, lower alkenyl, substituted lower alkenyl, lower alkynyl, substituted lower alkynyl phenyl …